Company news

Medtronic's Hugo Surgical Robot Wins FDA Clearance for General Surgery

Medtronic announced that its Hugo robotic-assisted surgery system has received FDA clearance for general surgery procedures, covering various upper abdominal surgeries as well as lower abdominal hernia and appendectomy, which account for about 3.5 million surgeries annually in the U.S.

Published · Updated · Source: Surgical Robotics Technology · AI translation
Illustration
Medtronic announced that the U.S. FDA has cleared the Hugo robotic-assisted surgery system for use in general surgery procedures. The clearance covers all upper abdominal general surgical procedures, including but not limited to cholecystectomy, Roux-en-Y gastric bypass, ventral hernia, and small bowel resection; lower abdominal procedures of inguinal hernia and appendectomy were also cleared. Medtronic states that these procedures account for about 3.5 million surgeries annually in the U.S., more than half of all soft-tissue procedures performed in the country each year. The Hugo system is in clinical use at a growing number of health systems and hospitals across the U.S. Medtronic says global Hugo procedure growth is running at more than two times the robotic surgery market and is on track to surpass 50,000 procedures by the end of its fiscal year; general surgery is also the highest-growth area for Hugo procedures outside the U.S. This information comes from the original source and was organized by AI.
Read the original source

Related news